Emergent BioSolutions
EBS
#6912
Rank
HK$4.72 B
Marketcap
HK$88.60
Share price
-4.71%
Change (1 day)
2.35%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$6.86 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are HK$6.86 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$7.04 B-23.21%
2023-12-31HK$9.16 B-34.03%
2022-12-31HK$13.89 B32.39%
2021-12-31HK$10.49 B-5.72%
2020-12-31HK$11.13 B15.4%
2019-12-31HK$9.64 B1.11%
2018-12-31HK$9.54 B673.46%
2017-12-31HK$1.23 B-57.45%
2016-12-31HK$2.89 B-0.89%
2015-12-31HK$2.92 B-2.15%
2014-12-31HK$2.99 B180.5%
2013-12-31HK$1.06 B12.63%
2012-12-31HK$0.94 B-6.36%
2011-12-31HK$1.01 B2.46%
2010-12-31HK$0.98 B26.12%
2009-12-31HK$0.78 B10.69%
2008-12-31HK$0.70 B-11.46%
2007-12-31HK$0.79 B2.83%
2006-12-31HK$0.77 B146.57%
2005-12-31HK$0.31 B-12.16%
2004-12-31HK$0.35 B
2002-12-31HK$0.14 B-67.71%
2001-12-31HK$0.45 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$903.42 B 13,062.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$606.57 B 8,737.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$478.79 B 6,876.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
HK$28.87 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$0.21 B-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.39 B-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$254.70 B 3,611.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel